Biomarkers of Coagulation, Endothelial Function, and Fibrinolysis in Critically Ill Patients with COVID-19: A Single-center Prospective Longitudinal Study

Overview

Journal J Thromb Haemost

Publisher Elsevier

Specialty Hematology

Date 2021 Apr 7

PMID 33826233

Citations 43

Authors

Ganeem K Juneja

Matthew Castelo

Calvin H Yeh

Samantha E Cerroni

Bettina E Hansen

James E Chessum

Joel Abraham

Erblin Cani

Dhruva J Dwivedi

Douglas D Fraser

Marat Slessarev

Claudio Martin

Scott McGilvray

Peter L Gross

Patricia C Liaw

Jeffrey I Weitz

Paul Y Kim

Affiliations

Soon will be listed here.

Abstract

Background: Immunothrombosis and coagulopathy in the lung microvasculature may lead to lung injury and disease progression in coronavirus disease 2019 (COVID-19). We aim to identify biomarkers of coagulation, endothelial function, and fibrinolysis that are associated with disease severity and may have prognostic potential.

Methods: We performed a single-center prospective study of 14 adult COVID-19(+) intensive care unit patients who were age- and sex-matched to 14 COVID-19(-) intensive care unit patients, and healthy controls. Daily blood draws, clinical data, and patient characteristics were collected. Baseline values for 10 biomarkers of interest were compared between the three groups, and visualized using Fisher's linear discriminant function. Linear repeated-measures mixed models were used to screen biomarkers for associations with mortality. Selected biomarkers were further explored and entered into an unsupervised longitudinal clustering machine learning algorithm to identify trends and targets that may be used for future predictive modelling efforts.

Results: Elevated D-dimer was the strongest contributor in distinguishing COVID-19 status; however, D-dimer was not associated with survival. Variable selection identified clot lysis time, and antigen levels of soluble thrombomodulin (sTM), plasminogen activator inhibitor-1 (PAI-1), and plasminogen as biomarkers associated with death. Longitudinal multivariate k-means clustering on these biomarkers alone identified two clusters of COVID-19(+) patients: low (30%) and high (100%) mortality groups. Biomarker trajectories that characterized the high mortality cluster were higher clot lysis times (inhibited fibrinolysis), higher sTM and PAI-1 levels, and lower plasminogen levels.

Conclusions: Longitudinal trajectories of clot lysis time, sTM, PAI-1, and plasminogen may have predictive ability for mortality in COVID-19.

Citing Articles

Entering the new digital era of intensive care medicine: an overview of interdisciplinary approaches to use artificial intelligence for patients' benefit.

Old O, Friedrichson B, Zacharowski K, Kloka J Eur J Anaesthesiol Intensive Care. 2025; 2(1):e0014.

PMID: 39916758 PMC: 11783618. DOI: 10.1097/EA9.0000000000000014.

A narrative review on lung injury: mechanisms, biomarkers, and monitoring.

Fan W, Gui B, Zhou X, Li L, Chen H Crit Care. 2024; 28(1):352.

PMID: 39482752 PMC: 11526606. DOI: 10.1186/s13054-024-05149-x.

SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model.

Heath S, Hermanns V, Coucha M, Abdelsaid M Transl Stroke Res. 2024; .

PMID: 39354270 DOI: 10.1007/s12975-024-01301-5.

Decreased Protein C Pathway Activity in COVID-19 Compared to Non-COVID Sepsis: An Observational and Comparative Cohort Study.

Ruhl H, Bode C, Becher T, Eckert S, Mohsen G, McRae H Biomedicines. 2024; 12(9).

PMID: 39335496 PMC: 11444193. DOI: 10.3390/biomedicines12091982.

Immunothrombosis: A bibliometric analysis from 2003 to 2023.

Hou M, Wu J, Li J, Zhang M, Yin H, Chen J Medicine (Baltimore). 2024; 103(37):e39566.

PMID: 39287275 PMC: 11404911. DOI: 10.1097/MD.0000000000039566.

References

Thachil J, Longstaff C, Favaloro E, Lippi G, Urano T, Kim P . The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis. J Thromb Haemost. 2020; 18(9):2408-2411. PMC: 7307061. DOI: 10.1111/jth.14956. View

Sadd C, Rowe T, Nazeef M, Kory P, Sultan S, Faust H . Thromboelastography to Detect Hypercoagulability and Reduced Fibrinolysis in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Patients. Crit Care Explor. 2020; 2(9):e0192. PMC: 7498137. DOI: 10.1097/CCE.0000000000000192. View

Brisson A, Matsui D, Rieder M, Fraser D . Translational research in pediatrics: tissue sampling and biobanking. Pediatrics. 2011; 129(1):153-62. DOI: 10.1542/peds.2011-0134. View

Bender R, Lange S . Adjusting for multiple testing--when and how?. J Clin Epidemiol. 2001; 54(4):343-9. DOI: 10.1016/s0895-4356(00)00314-0. View

Zuo Y, Warnock M, Harbaugh A, Yalavarthi S, Gockman K, Zuo M . Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients. Sci Rep. 2021; 11(1):1580. PMC: 7810990. DOI: 10.1038/s41598-020-80010-z. View

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

Fraser D, Slessarev M, Martin C, Daley M, Patel M, Miller M . Metabolomics Profiling of Critically Ill Coronavirus Disease 2019 Patients: Identification of Diagnostic and Prognostic Biomarkers. Crit Care Explor. 2020; 2(10):e0272. PMC: 7587450. DOI: 10.1097/CCE.0000000000000272. View

Hsu A, Liu Y, Zayac A, Olszewski A, Reagan J . Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia. Thromb Res. 2020; 196:375-378. PMC: 7511207. DOI: 10.1016/j.thromres.2020.09.030. View

Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D . COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020; 201(10):1299-1300. PMC: 7233352. DOI: 10.1164/rccm.202003-0817LE. View

10.

Fraser D, Cepinskas G, Slessarev M, Martin C, Daley M, Miller M . Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2020; 2(6):e0144. PMC: 7314329. DOI: 10.1097/CCE.0000000000000144. View

11.

Idell S . Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med. 2003; 31(4 Suppl):S213-20. DOI: 10.1097/01.CCM.0000057846.21303.AB. View

12.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

13.

Campbell W, Lazoura E, Okada N, Okada H . Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol Immunol. 2002; 46(2):131-4. DOI: 10.1111/j.1348-0421.2002.tb02669.x. View

14.

Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

15.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

16.

Yu B, Li X, Chen J, Ouyang M, Zhang H, Zhao X . Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J Thromb Thrombolysis. 2020; 50(3):548-557. PMC: 7286212. DOI: 10.1007/s11239-020-02171-y. View

17.

Yeh C, de Wit K, Levy J, Weitz J, Vaezzadeh N, Liaw P . Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms. J Trauma Acute Care Surg. 2020; 89(6):e177-e181. PMC: 7687878. DOI: 10.1097/TA.0000000000002938. View

18.

Singer M, Deutschman C, Seymour C, Shankar-Hari M, Annane D, Bauer M . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315(8):801-10. PMC: 4968574. DOI: 10.1001/jama.2016.0287. View

19.

Madhyastha H, Radha K, Nakajima Y, Omura S, Maruyama M . uPA dependent and independent mechanisms of wound healing by C-phycocyanin. J Cell Mol Med. 2008; 12(6B):2691-703. PMC: 3828884. DOI: 10.1111/j.1582-4934.2008.00272.x. View

20.

Goshua G, Pine A, Meizlish M, Chang C, Zhang H, Bahel P . Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020; 7(8):e575-e582. PMC: 7326446. DOI: 10.1016/S2352-3026(20)30216-7. View